Ribomic Inc. (4591.T)

JPY 80.0

(0.0%)

Revenue Summary of Ribomic Inc.

  • Ribomic Inc.'s latest annual revenue in 2023 was - JPY , down -100.0% from previous year.
  • Ribomic Inc.'s latest quarterly revenue in 2024 Q1 was 1 Million JPY , down 0.0% from previous quarter.
  • Ribomic Inc. reported a annual revenue of 65.96 Million JPY in annual revenue 2022, down -18.47% from previous year.
  • Ribomic Inc. reported a annual revenue of 80.9 Million JPY in annual revenue 2021, down -12.02% from previous year.
  • Ribomic Inc. reported a quarterly revenue of - JPY for 2023 Q1, down -100.0% from previous quarter.
  • Ribomic Inc. reported a quarterly revenue of - JPY for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of Ribomic Inc. (2023 - 2019)

Historical Annual Revenue of Ribomic Inc. (2023 - 2019)

Year Revenue Revenue Growth
2023 - JPY -100.0%
2022 65.96 Million JPY -18.47%
2021 80.9 Million JPY -12.02%
2020 91.96 Million JPY -24.0%
2019 121 Million JPY 0.0%

Peer Revenue Comparison of Ribomic Inc.

Name Revenue Revenue Difference
KOHJIN BIO CO LTD 4.77 Billion JPY 100.0%
PRISM BioLab Co.,LTD 112.92 Million JPY 100.0%
GNI Group Ltd. 26.01 Billion JPY 100.0%
Linical Co., Ltd. 12.3 Billion JPY 100.0%
Trans Genic Inc. 13.08 Billion JPY 100.0%
MEDINET Co., Ltd. 661.54 Million JPY 100.0%
Soiken Holdings Inc. 5.15 Billion JPY 100.0%
Cytori Cell Research Institute, Inc. 1.56 Billion JPY 100.0%
AnGes, Inc. 152.98 Million JPY 100.0%
OncoTherapy Science, Inc. 610.11 Million JPY 100.0%
Nxera Pharma Co., Ltd. 12.76 Billion JPY 100.0%
Immuno-Biological Laboratories Co., Ltd. 816.7 Million JPY 100.0%
NanoCarrier Co., Ltd. 135.5 Million JPY 100.0%
Carna Biosciences, Inc. 1.62 Billion JPY 100.0%
CanBas Co., Ltd. - JPY NaN%
D. Western Therapeutics Institute, Inc. 428.36 Million JPY 100.0%
RaQualia Pharma Inc. 1.9 Billion JPY 100.0%
Chiome Bioscience Inc. 682.46 Million JPY 100.0%
Kidswell Bio Corporation 2.43 Billion JPY 100.0%
PeptiDream Inc. 28.71 Billion JPY 100.0%
Oncolys BioPharma Inc. 63.03 Million JPY 100.0%
SanBio Company Limited - JPY NaN%
Healios K.K. 121 Million JPY 100.0%
BrightPath Biotherapeutics Co., Ltd. 72 Thousand JPY 100.0%
Kubota Pharmaceutical Holdings Co., Ltd. 39.88 Million JPY 100.0%
Delta-Fly Pharma, Inc. - JPY NaN%
StemRIM - JPY NaN%
CellSource Co., Ltd. 4.51 Billion JPY 100.0%
FunPep Company Limited 530 Thousand JPY 100.0%
Kringle Pharma, Inc. 69.25 Million JPY 100.0%
Stella Pharma Corporation 269.49 Million JPY 100.0%
TMS Co., Ltd. - JPY NaN%
Noile-Immune Biotech Inc. 316.81 Million JPY 100.0%
Cuorips Inc. 23.1 Million JPY 100.0%
K Pharma,Inc. 1 Billion JPY 100.0%
Takara Bio Inc. 43.5 Billion JPY 100.0%
ReproCELL Incorporated 2.42 Billion JPY 100.0%
PhoenixBio Co., Ltd. 1.71 Billion JPY 100.0%
StemCell Institute Inc. 2.48 Billion JPY 100.0%
Japan Tissue Engineering Co., Ltd. 2.51 Billion JPY 100.0%
CellSeed Inc. 190.13 Million JPY 100.0%